Serum protein profile analysis in patients with head and neck squamous cell carcinoma

Christine G. Gourin, Zhong Sheng Xia, Yan Han, Adam M. French, Ashli K. O'Rourke, David J Terris, Bao Ling Adam

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

Objectives: To analyze surface-enhanced laser desorption and ionization time-of-flight mass spectrometry (SELDI-TOF-MS) protein profiles of patients with head and neck squamous cell carcinoma (HNSCC) and healthy controls and to determine the sensitivity and specificity of SELDI assay for HNSCC detection before and after treatment. Design: Proteomic analysis and comparison of serum samples. Setting: Tertiary care academic medical center. Subjects: Seventy-eight patients with HNSCC and 68 healthy controls. Main Outcome Measures: Serum samples were prospectively collected from 78 patients with HNSCC and 68 healthy control volunteers. SELDI-TOF-MS was performed on serum samples to identify protein peaks in the range of 0 to 100 kDa. Classification analysis of the spectral data was performed and used to classify the disease status of the patients. Results: The SELDI-TOF-MS assay generated serum protein profiles ranging from 0 to 100 kDa. After background subtraction, mass calibration, and normalization, 545 protein peaks were identified. Classification tree analysis based on peak expression correctly classified patients with HNSCC with 82% sensitivity and 76% specificity. Subgroup analysis correctly classified 83% of oral cavity tumors, 81% of oropharyngeal tumors, and 88% of laryngeal tumors. Pretreatment and posttreatment samples were available from 12 patients, and the posttreatment samples were correctly classified in 86% of the patients at 3 months and 75% of the patients at 6 months. Conclusions: Proteomic SELDI-TOF-MS analysis of serum protein profiles distinguishes patients with HNSCC from controls with a high degree of sensitivity and specificity. Further investigation into the clinical utility of this technology in HNSCC detection and surveillance is warranted.

Original languageEnglish (US)
Pages (from-to)390-397
Number of pages8
JournalArchives of Otolaryngology - Head and Neck Surgery
Volume132
Issue number4
DOIs
StatePublished - Apr 1 2006

Fingerprint

Blood Proteins
Mass Spectrometry
Lasers
Sensitivity and Specificity
Proteomics
Serum
Carcinoma, squamous cell of head and neck
Neoplasms
Proteins
Tertiary Healthcare
Calibration
Mouth
Healthy Volunteers
Outcome Assessment (Health Care)
Technology

ASJC Scopus subject areas

  • Surgery
  • Otorhinolaryngology

Cite this

Serum protein profile analysis in patients with head and neck squamous cell carcinoma. / Gourin, Christine G.; Xia, Zhong Sheng; Han, Yan; French, Adam M.; O'Rourke, Ashli K.; Terris, David J; Adam, Bao Ling.

In: Archives of Otolaryngology - Head and Neck Surgery, Vol. 132, No. 4, 01.04.2006, p. 390-397.

Research output: Contribution to journalArticle

Gourin, Christine G. ; Xia, Zhong Sheng ; Han, Yan ; French, Adam M. ; O'Rourke, Ashli K. ; Terris, David J ; Adam, Bao Ling. / Serum protein profile analysis in patients with head and neck squamous cell carcinoma. In: Archives of Otolaryngology - Head and Neck Surgery. 2006 ; Vol. 132, No. 4. pp. 390-397.
@article{09feefddfeda4987af364c7170a25622,
title = "Serum protein profile analysis in patients with head and neck squamous cell carcinoma",
abstract = "Objectives: To analyze surface-enhanced laser desorption and ionization time-of-flight mass spectrometry (SELDI-TOF-MS) protein profiles of patients with head and neck squamous cell carcinoma (HNSCC) and healthy controls and to determine the sensitivity and specificity of SELDI assay for HNSCC detection before and after treatment. Design: Proteomic analysis and comparison of serum samples. Setting: Tertiary care academic medical center. Subjects: Seventy-eight patients with HNSCC and 68 healthy controls. Main Outcome Measures: Serum samples were prospectively collected from 78 patients with HNSCC and 68 healthy control volunteers. SELDI-TOF-MS was performed on serum samples to identify protein peaks in the range of 0 to 100 kDa. Classification analysis of the spectral data was performed and used to classify the disease status of the patients. Results: The SELDI-TOF-MS assay generated serum protein profiles ranging from 0 to 100 kDa. After background subtraction, mass calibration, and normalization, 545 protein peaks were identified. Classification tree analysis based on peak expression correctly classified patients with HNSCC with 82{\%} sensitivity and 76{\%} specificity. Subgroup analysis correctly classified 83{\%} of oral cavity tumors, 81{\%} of oropharyngeal tumors, and 88{\%} of laryngeal tumors. Pretreatment and posttreatment samples were available from 12 patients, and the posttreatment samples were correctly classified in 86{\%} of the patients at 3 months and 75{\%} of the patients at 6 months. Conclusions: Proteomic SELDI-TOF-MS analysis of serum protein profiles distinguishes patients with HNSCC from controls with a high degree of sensitivity and specificity. Further investigation into the clinical utility of this technology in HNSCC detection and surveillance is warranted.",
author = "Gourin, {Christine G.} and Xia, {Zhong Sheng} and Yan Han and French, {Adam M.} and O'Rourke, {Ashli K.} and Terris, {David J} and Adam, {Bao Ling}",
year = "2006",
month = "4",
day = "1",
doi = "10.1001/archotol.132.4.390",
language = "English (US)",
volume = "132",
pages = "390--397",
journal = "JAMA Otolaryngology - Head and Neck Surgery",
issn = "2168-6181",
publisher = "American Medical Association",
number = "4",

}

TY - JOUR

T1 - Serum protein profile analysis in patients with head and neck squamous cell carcinoma

AU - Gourin, Christine G.

AU - Xia, Zhong Sheng

AU - Han, Yan

AU - French, Adam M.

AU - O'Rourke, Ashli K.

AU - Terris, David J

AU - Adam, Bao Ling

PY - 2006/4/1

Y1 - 2006/4/1

N2 - Objectives: To analyze surface-enhanced laser desorption and ionization time-of-flight mass spectrometry (SELDI-TOF-MS) protein profiles of patients with head and neck squamous cell carcinoma (HNSCC) and healthy controls and to determine the sensitivity and specificity of SELDI assay for HNSCC detection before and after treatment. Design: Proteomic analysis and comparison of serum samples. Setting: Tertiary care academic medical center. Subjects: Seventy-eight patients with HNSCC and 68 healthy controls. Main Outcome Measures: Serum samples were prospectively collected from 78 patients with HNSCC and 68 healthy control volunteers. SELDI-TOF-MS was performed on serum samples to identify protein peaks in the range of 0 to 100 kDa. Classification analysis of the spectral data was performed and used to classify the disease status of the patients. Results: The SELDI-TOF-MS assay generated serum protein profiles ranging from 0 to 100 kDa. After background subtraction, mass calibration, and normalization, 545 protein peaks were identified. Classification tree analysis based on peak expression correctly classified patients with HNSCC with 82% sensitivity and 76% specificity. Subgroup analysis correctly classified 83% of oral cavity tumors, 81% of oropharyngeal tumors, and 88% of laryngeal tumors. Pretreatment and posttreatment samples were available from 12 patients, and the posttreatment samples were correctly classified in 86% of the patients at 3 months and 75% of the patients at 6 months. Conclusions: Proteomic SELDI-TOF-MS analysis of serum protein profiles distinguishes patients with HNSCC from controls with a high degree of sensitivity and specificity. Further investigation into the clinical utility of this technology in HNSCC detection and surveillance is warranted.

AB - Objectives: To analyze surface-enhanced laser desorption and ionization time-of-flight mass spectrometry (SELDI-TOF-MS) protein profiles of patients with head and neck squamous cell carcinoma (HNSCC) and healthy controls and to determine the sensitivity and specificity of SELDI assay for HNSCC detection before and after treatment. Design: Proteomic analysis and comparison of serum samples. Setting: Tertiary care academic medical center. Subjects: Seventy-eight patients with HNSCC and 68 healthy controls. Main Outcome Measures: Serum samples were prospectively collected from 78 patients with HNSCC and 68 healthy control volunteers. SELDI-TOF-MS was performed on serum samples to identify protein peaks in the range of 0 to 100 kDa. Classification analysis of the spectral data was performed and used to classify the disease status of the patients. Results: The SELDI-TOF-MS assay generated serum protein profiles ranging from 0 to 100 kDa. After background subtraction, mass calibration, and normalization, 545 protein peaks were identified. Classification tree analysis based on peak expression correctly classified patients with HNSCC with 82% sensitivity and 76% specificity. Subgroup analysis correctly classified 83% of oral cavity tumors, 81% of oropharyngeal tumors, and 88% of laryngeal tumors. Pretreatment and posttreatment samples were available from 12 patients, and the posttreatment samples were correctly classified in 86% of the patients at 3 months and 75% of the patients at 6 months. Conclusions: Proteomic SELDI-TOF-MS analysis of serum protein profiles distinguishes patients with HNSCC from controls with a high degree of sensitivity and specificity. Further investigation into the clinical utility of this technology in HNSCC detection and surveillance is warranted.

UR - http://www.scopus.com/inward/record.url?scp=33645852565&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33645852565&partnerID=8YFLogxK

U2 - 10.1001/archotol.132.4.390

DO - 10.1001/archotol.132.4.390

M3 - Article

C2 - 16618908

AN - SCOPUS:33645852565

VL - 132

SP - 390

EP - 397

JO - JAMA Otolaryngology - Head and Neck Surgery

JF - JAMA Otolaryngology - Head and Neck Surgery

SN - 2168-6181

IS - 4

ER -